five thousand diseases considered so rare that
drug companies ignored them
because they had no hope of recovering their research costs even if they found a
cure.
2
In 1983, Congress passed the Orphan Drug Act, which provided
incentives to make such work more profitable: research grants,
tax credits, and
exclusive rights to market and price drugs for rare diseases—so-called orphan
drugs—for seven years. In the decade before the act, fewer than ten orphan
drugs came to market. Since the act, roughly two
hundred such drugs have come
to market.
Or something as simple as deposits for cans and bottles. Not surprisingly,
recycling rates are much higher in states with deposits than in states without.
There is also less trash and litter. And if landfill space is at a premium—which it
is in most places—shouldn’t we be paying to dispose of our household trash
based on the volume we generate? What effect do you think that would have on
the quantity of consumer packaging?
Markets don’t solve social problems on their own (or else they wouldn’t be
social problems). But if we design solutions with the proper incentives,
it feels a
lot more like rowing downstream.
Dostları ilə paylaş: